A Novel Long-Term Treatment for Hemophilia A Using Shielded Living Therapeutics

Time: 1:45 pm
day: Day One


• Shielded living therapeutics utilize a novel cell platform combined with a novel biomaterial platform to potentially provide long lasting therapy for patients
• Pre-clinical data demonstrates both safety as well as efficacy in animal models
• Therapeutic is poised to enter the clinic this year